Patents by Inventor Steve Cartt

Steve Cartt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Administration of benzodiazepine compositions
    Patent number: 11793786
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: April 12, 2021
    Date of Patent: October 24, 2023
    Assignee: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20230104144
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: December 6, 2022
    Publication date: April 6, 2023
    Applicant: Neurelis, Inc.
    Inventors: Steve CARTT, David MEDEIROS, Garry Thomas GWOZDZ, Andrew LOXLEY, Mark MITCHNICK, David F. HALE, Edward T. MAGGIO
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20220241187
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: April 15, 2022
    Publication date: August 4, 2022
    Applicant: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20220117887
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: June 2, 2021
    Publication date: April 21, 2022
    Applicant: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20220062227
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: April 12, 2021
    Publication date: March 3, 2022
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • Administration of benzodiazepine compositions
    Patent number: 11241414
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: February 8, 2022
    Assignee: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20210299089
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: May 27, 2021
    Publication date: September 30, 2021
    Applicant: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • MULTIMODAL PARTICULATE FORMULATIONS
    Publication number: 20200038320
    Abstract: Multimodal particulate formulations of medicaments and methods for their use, e.g. by nasal or pulmonary administration for the treatment of various medical conditions, are provided.
    Type: Application
    Filed: October 7, 2019
    Publication date: February 6, 2020
    Inventors: Steve Cartt, David Medeiros, Edward T. MAGGIO
  • ACTH PROPHYLACTIC TREATMENT OF RENAL DISORDERS
    Publication number: 20190216901
    Abstract: Provided herein are methods for prophylactic treatment of renal disorders comprising administration of adrenocorticotropic hormone (ACTH), or fragment, analog, complex or aggregate thereof, or any combination thereof, to an individual suspected of having, predisposed to, or at risk of developing a renal disorder.
    Type: Application
    Filed: March 29, 2019
    Publication date: July 18, 2019
    Inventors: Steve Cartt, Rujun Gong
  • ACTH FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME
    Publication number: 20190160150
    Abstract: Provided herein are methods of treatment of acute respiratory distress syndrome comprising administration of adrenocorticotropic hormone (ACTH), or fragment, analog, complex or aggregate thereof, or any combination thereof, to an individual in need thereof.
    Type: Application
    Filed: January 18, 2019
    Publication date: May 30, 2019
    Inventors: James KNIGHT, Steve CARTT, David YOUNG, Patrice BECKER
  • ACTH prophylactic treatment of renal disorders
    Patent number: 10286041
    Abstract: Provided herein are methods for prophylactic treatment of renal disorders comprising administration of adrenocorticotropic hormone (ACTH), or fragment, analog, complex or aggregate thereof, or any combination thereof, to an individual suspected of having, predisposed to, or at risk of developing a renal disorder.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: May 14, 2019
    Assignees: Mallinckrodt ARD IP Limited, Rhode Island Hospital
    Inventors: Steve Cartt, Rujun Gong
  • ACTH for treatment of acute respiratory distress syndrome
    Patent number: 10232018
    Abstract: Provided herein are methods of treatment of acute respiratory distress syndrome comprising administration of adrenocorticotropic hormone (ACTH). or fragment, analog, complex or aggregate thereof, or any combination thereof, to an individual in need thereof.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: March 19, 2019
    Assignee: Mallinckrodt ARD IP Limited
    Inventors: James Knight, Steve Cartt, David Young, Patrice Becker
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20180235929
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: April 17, 2018
    Publication date: August 23, 2018
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • Administration of benzodiazepine compositions
    Patent number: 9763876
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: October 29, 2014
    Date of Patent: September 19, 2017
    Assignee: Hale Biopharma Ventures, LLC
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20170196884
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: March 27, 2017
    Publication date: July 13, 2017
    Inventors: Steve CARTT, David MADEIROS, Garry Thomas GWOZDZ, Andrew LOXLEY, Mark MITCHNICK, David HALE, Edward T. MAGGIO
  • ACTH PROPHYLACTIC TREATMENT OF RENAL DISORDERS
    Publication number: 20170106053
    Abstract: Provided herein are methods for prophylactic treatment of renal disorders comprising administration of adrenocorticotropic hormone (ACTH), or fragment, analog, complex or aggregate thereof, or any combination thereof, to an individual suspected of having, predisposed to, or at risk of developing a renal disorder
    Type: Application
    Filed: December 19, 2016
    Publication date: April 20, 2017
    Inventors: Steve Cartt, Rujun Gong
  • ACTH prophylactic treatment of renal disorders
    Patent number: 9550822
    Abstract: Provided herein are methods for prophylactic treatment of renal disorders comprising administration of adrenocorticotropic hormone (ACTH), or fragment, analog, complex or aggregate thereof, or any combination thereof, to an individual suspected of having, predisposed to, or at risk of developing a renal disorder.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: January 24, 2017
    Assignees: QUESTCOR PHARMACEUTICALS, INC., RHODE ISLAND HOSPITAL
    Inventors: Steve Cartt, Rujun Gong
  • MULTIMODAL PARTICULATE FORMULATIONS
    Publication number: 20160310421
    Abstract: Multimodal particulate formulations of medicaments and methods for their use, e.g. by nasal or pulmonary administration for the treatment of various medical conditions, are provided.
    Type: Application
    Filed: November 20, 2015
    Publication date: October 27, 2016
    Inventors: Steve Cartt, David Medeiros, Edward T. Maggio
  • ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
    Publication number: 20150065491
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: October 29, 2014
    Publication date: March 5, 2015
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • Administration of benzodiazepine compositions
    Patent number: 8895546
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: November 25, 2014
    Assignee: Hale Biopharma Ventures, LLC
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio